Matthew Jordan, Benoit Collette, Jon Garn, Jon Mann, Eric Croskey, Stephanie Hughes, Scott Schenone, Spencer Davis – Dialog

Designing a Wearable for Chronic Conditions

At Artefact, we believe that design can play an important role in helping achieve better health outcomes. By aligning contexts to experiences, building deeper connections between patients and their caregivers, and surfacing clear paths to better decisions, we can improve the life and care of the more than 130 million Americans who live with a chronic condition.

Dialog is a concept designed to help people with epilepsy gain a deeper understanding of their condition and make better decisions about their care. It gives them an easier way to manage triggers and thresholds while it empowers them to use assistance from family caregivers, first responders, and clinicians as needed.

Dialog consists of a wearable module that collects a range of meaningful data about the patient and her environment while a smartphone app provides the patient with insights into the factors that trigger events or lower thresholds.

The platform can connect to the person’s family and caregivers or even educate bystanders in cases of emergency. The easy, lightweight data input lets the patient log key information about her condition and subtle notifications help the patient respond better.

Dialog aims to help people with the condition live their lives to the fullest.

 

Process

Understanding the condition

Our first step was to build empathy with the people that live with epilepsy and their caregivers, so we could identify the priorities for which we needed to design.

Innovation workshop

In the process of ideation, we kept the solution as form-independent as long as possible, so we could hone in on the right user needs without being restrained by a form factor.

Design within constraints

We explored different form factors aiming to come up with the perfect balance among physical fit and comfort, data quality, and the emotional needs of the patient.

Concept validation

We went back to our target audiences–patient, family caregivers, and clinicians—to validate our decisions and obtain feedback that allowed us to fine tune Dialog.